药品许可交易（2019-2024）

本报告深入了解和分析公司如何以及为何进行许可交易。

本报告提供了2019年至2024年许可交易的详细资讯。

透过本报告可以了解双方宣布的授权交易的付款条款。这些资料提供了有关支付条款和其他交易条款的宝贵见解。

了解潜在合作伙伴谈判条款的弹性，并深入了解谈判过程，以了解条款谈判期间的预期结果。许多小型企业会要求提供付款条件的详细信息，但在包括付款方式和权利如何转让时，细节是关键。

本报告提供了自2019年以来宣布的许可案件，全面列出目前协议案件/合作伙伴资料库中记录的内容，并包括可用的财务条款，以及公司及其合作伙伴向证券交易委员会提交的实际许可协议文件的线上副本的连结。

主要优点

本报告为读者提供了以下主要好处：

• 了解2019年以来的交易完成趋势
• 查看许可交易
• 基准分析：确定交易的市场价值
• 财务状况
• 交易清单：依公司名称（A-Z）、依治疗领域、依技术类型
• 主要交易（金额基础）
• 最活跃的交易者
• 每笔交易的资产识别和交易条件
• 取得合约文件：深入了解交易结构
• 尽职调查：评估拟议交易条款对合作伙伴公司的适用性
• 节省数百小时的研究时间

调查范围

• 本报告目的是详细了解全球领先生物製药公司的许可趋势和交易结构。

此报告包含以下资讯：

• 生物製药产业许可交易的趋势
• 许可交易结构：概述
• 整个製药业的许可交易记录列表
• 主要许可交易（价值基础）
• 最活跃的许可贸易伙伴
• 用于授权交易的主要合作伙伴资源

此报告列出了可获得资讯的交易：

• 依公司名称（A-Z）
• 依交易金额
• 依治疗领域
• 依技术型
• 每个交易标题都透过网路连结连结到实际交易记录的线上版本。
• 此报告提供了对许可协议的可用合约文件的全面存取。

透过分析合约协议，尽职调查可以：

• 授予和选择了哪些权利？
• 合约授予了哪些权利？
• 授予哪些专有权？
• 合约的付款结构是怎样的？
• 如何审核销售和付款？
• 合约期限是多久？
• 合约的主要条款是如何定义的？
• 如何对待和拥有知识产权？
• 谁负责商业化？
• 谁负责开发、供应和製造？
• 如何管理保密和发布？
• 如何解决争议？
• 什么情况下可以取消合约？
• 如果所有者发生变化会怎样？
• 已商定何种类型的分授权或分包条款？
• 公司需要哪些样板条款？
• 哪些样板条款会根据合作伙伴和交易类型的不同而有所不同？
• 每家公司都主张合约法中的哪一个管辖权？

目录

执行摘要

第一章 简介

第2章 许可证交易趋势

• 简介
• 许可交易的定义
• 授权交易趋势（2019年后）
  • 达成许可交易：依年份（2019-2024年）
  • 达成许可交易：依开发阶段划分（2019-2024年）
  • 达成许可交易：依行业分类（2019-2024年）
  • 达成许可交易：依治疗领域划分（2019-2024年）
  • 达成许可交易：依技术类型划分（2019-2024年）
  • 达成许可交易：针对最活跃的公司（2019-2024年）
• 签订许可交易协议的原因
• 未来的授权交易

第3章 许可交易结构：概述

• 简介
• 许可交易的结构

第四章 主要许可交易

• 简介
• 主要许可交易（价值基础）

第五章 最活跃的25家许可证贸易公司

• 简介
• 前 25 位最活跃的授权交易合作伙伴（达成交易的公司）

第6章 许可交易清单（包括合约详细资料）

• 简介
• 授权交易协议（2019-2024）
• 交易列表
• 交易清单：达成许可交易，依公司名称（A-Z）
• 交易清单：达成许可交易，依治疗领域
• 交易清单：达成许可交易，依技术类型

关于怀尔德伍德创投公司

• 目前的合作关係
• 当前合约
• Current Partnering 发布的最新报告标题

Licensing Deals in Pharmaceuticals provides a detailed understanding and analysis of how and why companies enter licensing deals.

Fully revised and updated, the report provides details of licensing deals from 2019 to 2024.

The report provides access to licensing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The initial chapters of this report provide an orientation of licensing dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview and analysis of the trends in licensing as well as a discussion on the merits of the type of deal.

Chapter 3 provides an overview of the structure of licensing deals.

Chapter 4 provides a review of the leading licensing deals since 2019. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

Chapter 5 provides a comprehensive listing of the top 25 most active licensing dealmaker companies. Each deal title links via Current Agreements deals and alliances database to an online version of the full deal record, and where available, the actual contract document, providing easy access to each deal record on demand.

Chapter 6 provides a comprehensive and detailed review of licensing deals organized by company A-Z, therapy, technology and industry type signed and announced since 2019 where a contract document is available. Contract documents provide an indepth insight into the actual deal terms agreed between the parties with respect to the licensing deal.

The deal directory includes a comprehensive listing of all licensing deals announced since 2019. Each listing is organized as a deal directory by company A-Z, therapeutic area and technology type. Each deal title links via hyperlink to an online version of the deal record including, where available, the actual contract document.

The report also includes numerous table and figures that illustrate the trends and activities in licensing dealmaking since 2019.

In conclusion, this report provides everything a prospective dealmaker needs to know about licensing alliances.

Key benefits

Licensing Deals in Pharmaceuticals provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Report scope

• Licensing Deals in Pharmaceuticals is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading biopharma companies worldwide.

Licensing Deals in Pharmaceuticals includes:

• Trends in licensing dealmaking in the biopharma industry
• Overview of licensing deal structure
• Directory of licensing deal records covering pharmaceutical and biotechnology
• The leading licensing deals by value
• Most active licensing dealmakers
• The leading licensing partnering resources

In Licensing Deals in Pharmaceuticals, the available deals are listed by:

• Company A-Z
• Headline value
• Therapeutic area
• Technology type
• Each deal title links via Weblink to an online version of the actual deal record, providing easy access to each contract document where available.
• Licensing Deals in Pharmaceuticals provides comprehensive access to available records for licensing deals, including contract documents where available.

Analyzing contract agreements allows due diligence of:

• What are the rights granted or optioned?
• What rights are granted by the agreement?
• What exclusivity is granted?
• What is the payment structure for the deal?
• How are sales and payments audited?
• What is the deal term?
• How are the key terms of the agreement defined?
• How are intellectual property rights handled and owned?
• Who is responsible for commercialization?
• Who is responsible for development, supply, and manufacture?
• How is confidentiality and publication managed?
• How are disputes resolved?
• Under what conditions can the deal be terminated?
• What happens when there is a change of ownership?
• What sublicensing and subcontracting provisions have been agreed?
• Which boilerplate clauses does the company insist upon?
• Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
• Which jurisdiction does the company insist upon for agreement law?

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in licensing dealmaking

• 2.1. Introduction
• 2.2. Definition of licensing deal
• 2.3. Trends in licensing deals since 2019
  • 2.3.1. Licensing dealmaking by year, 2019-2024
  • 2.3.2. Licensing dealmaking by phase of development, 2019-2024
  • 2.3.3. Licensing dealmaking by industry sector, 2019-2024
  • 2.3.4. Licensing dealmaking by therapy area, 2019-2024
  • 2.3.5. Licensing dealmaking by technology type, 2019-2024
  • 2.3.6. Licensing dealmaking by most active company, 2019-2024
• 2.4. Reasons for entering into licensing partnering deals
• 2.5. The future of licensing deals

Chapter 3 - Overview of licensing deal structure

• 3.1. Introduction
• 3.2. Licensing agreement structure

Chapter 4 - Leading licensing deals

• 4.1. Introduction
• 4.2. Top licensing deals by value

Chapter 5 - Top 25 most active licensing dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active licensing dealmakers

Chapter 6 - Licensing deals including contracts directory

• 6.1. Introduction
• 6.2. Licensing deals with contracts 2019-2024
• Deal directory
• Deal directory - licensing dealmaking by companies A-Z
• Deal directory - licensing dealmaking by therapy area
• Deal directory - licensing dealmaking by technology type

About Wildwood Ventures

• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of licensing
• Figure 2: Trends in licensing deal announcements, 2019-2024
• Figure 3: Licensing deals signed at each phase of development, 2019-2024
• Figure 4: Licensing deals by industry sector, 2019-2024
• Figure 5: Licensing deals by therapy area, 2019-2024
• Figure 6: Licensing deals by technology type, 2019-2024
• Figure 7: Top 25 most active licensing dealmakers, 2019-2024
• Figure 8: Top licensing deals by value, 2019-2024
• Figure 9: Most active licensing dealmakers, 2019-2024